Key result
COVID-19 linked to acute MI and cardiogenic shock driven by three-vessel coronary thrombosis.
Why the study?
COVID-19 is associated with coronary artery thrombosis, but cases involving three-vessel thrombosis are uniquely rare and not well documented.
Case Report (n=1)
Highlights a unique case of three-vessel coronary artery thrombosis causing cardiogenic shock in a patient with COVID-19 pneumonia, emphasizing the need for a low threshold for diagnosing MI in this population.
May support low MI threshold in COVID-19 chest pain; leaves open causal links pending higher-level evidence.
Key Clinical Message: Respiratory viruses, particularly COVID-19, can be associated with severe cases of myocardial infarction (MI). Physicians should have a low threshold for MI in COVID-19 patients who present with persistent chest pain as MI in rapidly deteriorating cases can be missed. Prompt response includes both timely diagnosis and swift treatment. Abstract: The coronavirus disease 2019 (COVID-19) is associated with coronary artery thrombosis. Many cases of single-vessel and few cases of two-vessel thrombosis were reported. Herein, we report a unique association in a middle-aged man diagnosed with COVID-19 and presented later with acute myocardial infarction causing cardiogenic shock. The patient was found to have three-vessel thrombosis.
No takes yet. Share an insight, caveat, or question.
Habib et al. (2023) conducted a case report in COVID-19 and acute myocardial infarction (n=1). COVID-19 infection was evaluated on Three-vessel coronary artery thrombosis. A middle-aged man with COVID-19 developed acute myocardial infarction causing cardiogenic shock due to three-vessel coronary artery thrombosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Clinical Case Reports